Javascript must be enabled to continue!
Study on the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes
View through CrossRef
The objective of this research was to study the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes. For this purpose, 52 patients with diabetes who were hospitalized from September 2019 to May 2021 were selected as the research objects. They were grouped according to the severity of the disease, which was pre-diabetes (n=16), mild (n=25), and moderate (n=16). =11), another 20 healthy subjects were taken as the control group, and the levels of PPARγ, Aβ1-42, miR-155 in each group were measured, and the correlation between changes in the levels of various indicators and the occurrence and development of diabetes was explored. Results showed that comparison of age, gender, course of disease, BMI, living habits, comorbidities, and high-density lipoprotein among the groups of diabetic patients (P>0.05); the levels of total cholesterol, triglycerides and low-density cholesterol decreased with the development of diabetes (P<0.05) ); Compared with the healthy group, the levels of PPARγ and miR-155 were significantly reduced, and the levels of Aβ1-42 were significantly increased (P<0.05); compared with the prediabetes, the levels of mild and moderate PPARγ and miR-155 showed a downward trend, and Aβ1 -42 level showed an upward trend (P<0.05); PPARγ and miR-155 levels were negatively correlated with pre-diabetes, mild, and moderate; Aβ1-42 was positively correlated with pre-diabetes, mild, and moderate (P<0.05) ; PPARγ, Aβ1-42, miR-155 levels can effectively predict the occurrence and development of diabetes, and the sensitivity, specificity and accuracy of the detection of diabetes by various indicators, positive predictive value and negative predictive value are significantly higher. It is concluded that PPARγ, Aβ1-42, miR-155 are closely related to the occurrence and development of diabetes, and there are many influencing factors of diabetes. Clinical intervention measures can be taken according to specific conditions.
Title: Study on the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes
Description:
The objective of this research was to study the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes.
For this purpose, 52 patients with diabetes who were hospitalized from September 2019 to May 2021 were selected as the research objects.
They were grouped according to the severity of the disease, which was pre-diabetes (n=16), mild (n=25), and moderate (n=16).
=11), another 20 healthy subjects were taken as the control group, and the levels of PPARγ, Aβ1-42, miR-155 in each group were measured, and the correlation between changes in the levels of various indicators and the occurrence and development of diabetes was explored.
Results showed that comparison of age, gender, course of disease, BMI, living habits, comorbidities, and high-density lipoprotein among the groups of diabetic patients (P>0.
05); the levels of total cholesterol, triglycerides and low-density cholesterol decreased with the development of diabetes (P<0.
05) ); Compared with the healthy group, the levels of PPARγ and miR-155 were significantly reduced, and the levels of Aβ1-42 were significantly increased (P<0.
05); compared with the prediabetes, the levels of mild and moderate PPARγ and miR-155 showed a downward trend, and Aβ1 -42 level showed an upward trend (P<0.
05); PPARγ and miR-155 levels were negatively correlated with pre-diabetes, mild, and moderate; Aβ1-42 was positively correlated with pre-diabetes, mild, and moderate (P<0.
05) ; PPARγ, Aβ1-42, miR-155 levels can effectively predict the occurrence and development of diabetes, and the sensitivity, specificity and accuracy of the detection of diabetes by various indicators, positive predictive value and negative predictive value are significantly higher.
It is concluded that PPARγ, Aβ1-42, miR-155 are closely related to the occurrence and development of diabetes, and there are many influencing factors of diabetes.
Clinical intervention measures can be taken according to specific conditions.
Related Results
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
Objectives
The activation of coagulation and fibrinolysis plays a critical role in the incidence of coronary events. MicroRNAs (miRNAs) are small non-coding ribon...
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Abstract
Background
Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological and patholog...
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Abstract
MicroRNAs are a class of non‐coding molecules found to regulate a variety of cellular functions in health and disease. Dysregulation of microRNAs is invo...
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Abstract
Abstract 3896
Poster Board III-832
We previously reported the finding of significantly raised levels of mature microRNA 16 (mi...
Peroxisome proliferator‐activated receptor γ upregulates galectin‐9 and predicts prognosis in intestinal‐type gastric cancer
Peroxisome proliferator‐activated receptor γ upregulates galectin‐9 and predicts prognosis in intestinal‐type gastric cancer
The importance of PPARγ (peroxisome proliferator‐activated receptor γ) in gastric cancer (GC) is unclear. We investigated the role of PPARγ in GC cell lines and an animal model, an...
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
Introduction: Acute myocardial infarction (AMI) is a severe coronary heart disease. Targeted miRNAs studies implicated two main pathways in the regulation of AMI namely pro-apopt...
<b>Circulating MicroRNA Profiles as Early Indicators of Breast Cancer Metastatic Potential</b>
<b>Circulating MicroRNA Profiles as Early Indicators of Breast Cancer Metastatic Potential</b>
Background: Breast cancer outcomes are strongly influenced by metastatic progression, and conventional clinicopathological features may not fully reflect tumor aggressiveness. Circ...
Entwicklung von chemischen Tools für nukleäre Rezeptoren
Entwicklung von chemischen Tools für nukleäre Rezeptoren
Nukleäre Rezeptoren (NRs) sind ligandengesteuerte Transkriptionsfaktoren, die sich aus einer Superfamilie von 48 humanen Mitgliedern zusammensetzt. Seit vielen Jahrzehnten stellen ...

